4.4 Article

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

Related references

Note: Only part of the references are listed.
Review Physiology

PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING

Peter J. Goadsby et al.

PHYSIOLOGICAL REVIEWS (2017)

Article Clinical Neurology

Migraine

K. R. Peck et al.

NEUROEPIDEMIOLOGY (2016)

Article Neurosciences

Migraine: Multiple Processes, Complex Pathophysiology

Rami Burstein et al.

JOURNAL OF NEUROSCIENCE (2015)

Editorial Material Clinical Neurology

Migraine: The seventh disabler

T. J. Steiner et al.

CEPHALALGIA (2013)

Article Mathematical & Computational Biology

Superchain procedures in clinical trials with multiple objectives

George Kordzakhia et al.

STATISTICS IN MEDICINE (2013)

Article Anesthesiology

Adherence with Migraine Prophylaxis in Clinical Practice

Ariel Berger et al.

PAIN PRACTICE (2012)

Review Clinical Neurology

Current practice and future directions in the prevention and acute management of migraine

Peter J. Goadsby et al.

LANCET NEUROLOGY (2010)

Article Clinical Neurology

Migraine prevalence, disease burden, and the need for preventive therapy

R. B. Lipton et al.

NEUROLOGY (2007)

Article Clinical Neurology

CGRP may play a causative role in migraine

LH Lassen et al.

CEPHALALGIA (2002)